Stanniocalcin 2 (STC2) is a potent biomarker of hepatocellular carcinoma with its expression being augmented in Nrf1α-deficient cells, but diminished in Nrf2-deficient cells https://www.biorxiv.org/content/10.1101/2023.05.15.540796v1?med=mas
Stanniocalcin 2 (STC2) is a potent biomarker of hepatocellular carcinoma with its expression being augmented in Nrf1α-deficient cells, but diminished in Nrf2-deficient cells https://www.biorxiv.org/content/10.1101/2023.05.15.540796v1?med=mas